FindTrial
Sign In

Research on the relationship between gut microbiota and immune microenviroment of pancreatic cancer

Research on the relationship between gut microbiota and immune microenviroment of pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033882
Enrollment
Unknown
Registered
2020-06-15
Start date
2020-06-20
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Pancreatic cancer:No
Benign pancreatic diseases:No

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The pancreatic cancer diagnosed by pathology; 2. Aged 18-70 year-old; 3. Willing to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Metastatic pancreatic cancer originating from other tissues or pancreatic neuroendocrine tumor; (2) Bacterial dysentery, amoebic dysentery, chronic schistosomiasis, intestinal tuberculosis, ischemic colitis, radioactive colitis, unshaped colitis; (3) Pregnant or lactating women; (4) Patients with liver cirrhosis, diabetes, renal failure, severe fatty liver and obesity; (5) Intestinal microbial agents or antibiotics were used 2 weeks before the collection of specimens.

Design outcomes

Primary

MeasureTime frame
Immune cells in tumor tissue; Tissue microbiota 16sRNA;Gut microbiota16sRNA;Immune factors in blood;—

Countries

China

Contacts

Public ContactQing Zhu

West China Hospital, Sichuan University

newzhuqing1972@163.com+86 18009252290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026